Dave Asprey: Biden’s FDA banned cheap peptides while protecting Ozempic, MAHA will change that
Dave Asprey told Jason Rantz that Biden's FDA peptide crackdown protected Ozempic's $26B profits while banning the cheaper compounded alternatives patients actually use.
Watch: Dave Asprey: Biden BANNED These Peptides While Approving Ozempic | 4 mins
The Biden administration classified dozens of popular peptide compounds as too dangerous for compounding pharmacies to produce. The biggest-selling drug in the country is a peptide. Dave Asprey, and the Trump administration, noticed.
Asprey, the father of biohacking, joined The Jason Rantz Show on Seattle Red 770 AM this week after years of watching the FDA draw a line between the peptides it protects and the peptides it bans.
“So peptides are really simple idea,” Asprey told Rantz. “So all proteins are made up of something called amino acids. People have usually heard of amino acids, even if you don’t really know what they are, they’re just letters in the alphabet. And if you put those letters together into a word, that’s a peptide, and if you put those words together into a paragraph, that’s a protein, right? So what we’re doing is we’re breaking these proteins down into signaling molecules that are a small number of these amino acids stuck together. And when you do that, your body’s listening for the signal. And biohackers, we just want to get a signal in to make our body do what we want, or make our mind do what we want. So this is a powerful way to hack into your biology and, say, heal faster than you’re supposed to.”
That same basic chemistry is what makes GLP-1 drugs work. Semaglutide, the active ingredient in Ozempic, is a peptide-based compound that mimics the gut hormone GLP-1. As SeattleRed’s coverage of the FDA’s BPC-157 review noted, Novo Nordisk generated $26 billion off semaglutide in 2024 alone, and the FDA championed every bit of it.
Biden’s crackdown and the logic problem
The Biden-era FDA added more than two dozen peptide compounds to a restricted list, citing safety risks including cancer and liver, kidney and heart problems. Compounding pharmacies caught producing them faced fines, legal action, and potential loss of their state licenses.
“The Biden administration said anything was unsafe for human testing? Is that, like in the definition under irony, I’m talking about something out of Wuhan anyway, that’s hilarious,” Asprey jokingly told Rantz. “But yeah, they did. And there are a lot of people healing from long covid using peptides to be really clear, they can help. So the absurdity of it is should not be lost on anyone listening.”
The MAHA push to restore access
RFK Jr. has publicly called the Biden-era restrictions an outright war on peptides and vowed to end them.
The FDA is now scheduled to hold a July advisory meeting to review whether at least seven of the most popular restricted compounds, including BPC-157, should be available to compounding pharmacies again. The peptide fight is part of a wider MAHA overhaul at the FDA that Asprey recently covered with Rantz, one that now includes reversals on hormone replacement therapy and testosterone guidance.
What Asprey says about using peptides
Asprey puts the number of compounds used in biohacking at around 500, with effects ranging well beyond muscle recovery.
“There’s about 500 or so, maybe slightly less than that, that we commonly use in the world of biohacking, and a lot of them came out of Russia many years ago,” he said. “Some have been discovered in laboratories recently. There’s deep sleep inducing peptide, one of my favorites is called Melanotan, or alpha MSH. And bodybuilders have been using it since probably the early 90s, but biohackers like me use it because it makes your brain work better, and yeah, it gives you a tan in 20 minutes of sun exposure. So you inject the thing, go out in the sun for 20 minutes, and then you have an amazing golden tan. That’s a real tan. It’s not a spray tan. And having a tan is really healthy. And if you live in Seattle, that was your entire year’s worth of sun just to get the tan in that 20 minutes. I’m just kidding.”
Dave Asprey on peptide safety
On the safety argument, Asprey rejected the framing that limited human testing is the same thing as proven danger.
“Some of them are not that well tested in humans, which doesn’t mean that they aren’t tested in humans, and it doesn’t mean they’re unsafe, and it just means that they aren’t tested,” he added. “One of the things that big pharma likes to do is they like to say, anything on the market has to be tested to our our standards of hundreds of millions of dollars of tests and all that, this is not necessary now. Something is safe, and what they’re doing is they’re holding the competition back, because if you can’t come up with a couple 100 million dollars of testing, no one can compete. This is why healthcare is incredibly expensive and slow in the US.”
“Almost any anything you want to improve or change, there’s a peptide for that,” Asprey noted.
Peptide use should be discussed with a healthcare provider, which may become much easier in July.
Listen to The Jason Rantz Show on weekday afternoons from 3 p.m. – 7 p.m. on Seattle Red on 770 AM (HD Radio 97.3 FM HD-Channel 3). Subscribe to the podcast here. Follow Jason Rantz on X, Instagram, YouTube, and Facebook.




Comments
0 Comments